DRUG (DRUG) Stock Price & Analysis
DRUG (DRUG) rose 2.69% to USD 66.91 as of September 9, 2026 at 12:48 UTC, according to Nexqual real-time market data.
DRUG last closed at USD 66.91; the session ranged USD 64.3–67.77 on volume of 65,007 shares. Market capitalization is —, with a 52-week range of USD 41.48–123.75 (NCM). Source: Nexqual, September 9, 2026 at 12:48 UTC.
Key Statistics (as of September 9, 2026 at 12:48 UTC)
| Price | USD 66.91 |
|---|---|
| Change | ▲ 2.69% (up) |
| Previous Close | USD 66.91 |
| Open | USD 66.91 |
| Day Range | USD 64.3 – 67.77 |
| 52-Week Range | USD 41.48 – 123.75 |
| Volume | 65,007 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (DRUG)
Nexqual's technical model rates DRUG "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 12:48 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.42 (neutral) |
| vs SMA50 | Below (USD 74.49) |
| MACD | -2.25 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 7.15 | ▼ 9.15% |
| VRAX | Virax Biolabs Group Limited | USD 2.63 | ▲ 2.73% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.47 | ▲ 7.5% |
| BIVI | BioVie Inc. | USD 2.07 | ▲ 1.97% |
| MEGL | Magic Empire Global Limited | USD 1.25 | ▼ 0.79% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 12:48 UTC. This page is informational and not investment advice.